|
|
 |
|
Viewing report
|
|
|
|
HIV Drugs - Global Strategic Business Report
Global Industry Analysts, Inc., April 2010, Pages: 484
This report analyzes the Worldwide markets for HIV Drugs in US$ Million. The report provides separate comprehensive analytics for US, Canada, Japan, Europe and Rest of World. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 52 companies including Abbott Laboratories, Boehringer Ingelheim GmbH , Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Koronis Pharmaceuticals, Inc., Merck & Co., Inc., Pfizer, Inc., Tibotec BVBA, ViiV Healthcare, and VIRxSYS Corp. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Key Companies: HIV - Companies Co-operate and Co-formulate to Stay Competitive in a Tight HIV Market
The HIV Market Outlook to 2016
HIV / AIDS - Pipeline Review, H1 2012
Market and Product Forecasts: HIV - Rising prevalence and novel STRs boost sales in the US and Europe
The Antivirals Pipeline: Competitive Review
Product Profiles: HIV - Growing number of FDCs further commoditizes the HIV market
HIV-1 Infection - Pipeline Review, H1 2012
Competitor Analysis: HIV Vaccines
HIV / AIDS - Pipeline Review, H2 2011
The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
|
|
|
|
